Biosimilars – Biosimilars on the cusp of a new era

(EMAILWIRE.COM, September 04, 2015 ) Portland, OR — The biosimilars market is undergoing rapid change with developments such as the recent approvals of infliximab and trastuzumab heralding a new era. In order to keep up with the pace of change in the marketplace, regulatory agencies have been…
http://www.emailwire.com/release/198334-Biosimilars-Biosimilars-on-the-cusp-of-a-new-era.html